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                                               INTRODUCTION 
                             Rheumatoid arthritis (RA) is a chronic systemic disease 
affecting primarily the synovium, leading to joint damage and bone destruction1  
RA causes significant morbidity as a result of synovial inflammation, joint 
destruction and associated disability 2. Epidemiological studies have shown an 
increased premature mortality in patients with RA compared with the general 
population3-7. Several investigators reported an excess of cardiovascular 
morbidity and mortality among RA patients62,-65. 
                Though  rheumatoid vasculitis in severe RA cases with high 
rheumatoid factor titres occasionally causes acute myocardial infarction  the 
overwhelming   majority of cardiovascular deaths in RA result from accelerated 
atherosclerosis2,8,9. 
              Risk factors for atherosclerotic events and cardiovascular disease 
include male sex, increased age, elevated plasma total cholesterol (TC) and low-
density lipoprotein cholesterol (LDL-C), decreased high-density lipoprotein 
cholesterol (HDL-C), high blood pressure, smoking and diabetes mellitus10-13. 
Approximately 50% of atherosclerotic coronary artery disease (CAD) in the 
community occurs in the absence of traditional risk factors14. 
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             In general, and with some variations between different studies, the lipid 
profile of patients with active or untreated RA is primarily characterized by a 
decrease in serum levels of HDL-C whereas contrasting results have been 
published on the serum levels of TC and LDL-C15-20. Importantly, the reduction 
in HDL-C has as a consequence the increase in the TC/HDL-C ratio15. This 
ratio represents an atherogenic index, which is an important prognostic marker 
for cardiovascular disease15. Indeed, the risk of myocardial infarction increases 
considerably when this ratio is higher than five, and it should ideally be four or 
less15,16. 
           There are few studies in India about lipid profile abnormality in 
Rheumatoid arthritis and inflammatory activity altering lipid profile in RA 
patients.There is lacuna of knowledge about this aspect of disease in Indian 
patient.This study aims to address this issue.   
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                                                    AIMS OF THE STUDY 
 
1.   To study the Lipid profile abnormalities in Rheumatoid arthritis patients. 
2.   To assess the correlation between Lipid abnormalities and severity of the 
disease. 
3.  To assess the role of Lipid abnormalities in the development of 
cardiovascular disease in   Rheumatoid arthritis. 
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                                                  HISTORICAL REVIEW: 
The rheumatic disease have been recognized since the fifth century before 
Christ under the title of “ARTHRITIS” (COPEMAN 1969) .The rheumatism 
was probably introduced by Galen in medieval times to designate pain caused 
by one of four humours21. 
The first descriptionofthedisease is usually attributed to LANDRE- 
BEAUVAIS (1800) who published his observations as a thesis SAIVEGES 
(1763) had previously written about a secondary type of arthritis which might 
follow acute rheumatisim . Sir ALFRED BARRING GUARD described RA 
and suggested that it was a different disease from gout (1859)23. 
STRAGEWAYS (1907) advanced our knowledge about the pathology of the 
disease. The theory of focal sepsis was introduced by WILLIAM HARTER 
(1901).Rheumatoid factor was discovered by ross23. 
Shortly afterwards, the syndrome was described independently by 
CHAUFFARD in france and Juvenile RA is Still called chauffard still”s 
disease21. 
FERESTER (1930) suggested treatment with gold salt.23 The discovery that the 
disease process could be reversed temporarily by cortisone was made by 
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HERCH and KERDALL for which  they jointly received the novel price in 
195023. 
In 1953, caplan described the rheumatoid pneumoconiosis in coal workers who 
had a history of exposure to dust23. 
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                                               DEFINITION: 
Rheumatoid Arthritis is defined as a chronic systemic inflammatory disorder 
characterized by deforming symmetrical polyarthritis of varying extent and 
severity, associated with synovitis of  joints and tendon sheath, articular 
cartilage loss, erosion of juxta articular bone and in most patient the presence of 
IgM rheumatoid factor in the blood.23 
EPIDEMIOLOGY: 
*Incidence was 54/1 lakh in women 
                         -24.5/1 lakh in men23. 
80% of all patients developing the disease between the ages of 35 and 50 years. 
However the incidence increased to a maximum in women over 45 years and 
men continued to raise into seventh decade.30 
          *prevalence of RA lies between 0.8 and 1.1 percent of adult population. 
        *Women are affected 3 times more often than men23. 
ETIOLOGY: 
The initiating cause of rheumatoid arthritis remains unclear. 
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1. Genetic factors :- 
Genetic studies of the distribution of RA in families and in mono & 
dizygotic twins show that there is a small but definite contribution of 
genetic factors to the disease.  
In twins studies, there is around 30% concordance of disease in identical 
twins and around 5% in non-identical twins. 
- 10% of patients with RA will have an affected first degree relatives. 
- Recent studies have shown an association between HLA-DR, (HLA-
DW4 and HLA-DW14) and seropositive disease. In Indians RA is 
most commonly associated with HLA-DR1. 
- More specially , the disease susceptibility is associated with sharped  
epitope of specific aminoacid sequence on the beta-1 chain of a 
number of class II –alleles located in the third allelic hypervariable 
region of HLA-DR B1, between aminoacid residue 67 and 74 which 
flank the T-cell recognition site23. 
2.Environmental factors: 
It has been suggested that RA might be a manifestation of the response to 
an infectious agent in a genetically susceptible host. 
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- Organism included EBV , CMV , Parovirus B1931, Rubella virus and 
mycoplasma. 
- Cigarette smoking was associated with increased risk of RA. 
- Exposure silica dust, organic solvent, mineral oils were associated 
with increased risk of RA. 
3.Host factors. 
- Exposure to oral contraceptive pills confers protection and postone 
the onset of RA. 
-Pregnancy is associated with suppression of disease. The incidence of 
RA is increased following parturition and during laction23. 
-The incidence of disease is increased in old age male because of low 
testosterone23. 
PATHOLOGY:  
1.Rheumatoid disease process in the joints is characterized by  
     a. Synovitis 
     b. Inflammatory effusion 
     c. Cellular exudates into the joint space 
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     d. Damage to tendon, ligament and bone in and around 
articulating surfaces of the joint by the proliferating inflammatory 
tissue called pannus26. 
2. Extra articular features associated with RA consist of two types 
of lesion. 
• First is fibrointimal hyperplasia without inflammatory 
changes leading to vascular occlusion. 
• Second lead to extravascular lymphocyte macrophage 
granuloma lesion of RA27. 
3.Extravascular nodule formation in areas subject to pressure is 
characteristic   granulomatous lesion of RA. 
PATHOGENESIS 
       The inflammatory synovial membrane produces large amount 
of immunoglobulins mainly as RF. The cellular basis for 
production of RF is well established. 
Lymphokines: 
      The inflammatory synovium contains activated T- lymphocyte, 
which produce lymphokines into the synovial fluid. These in turn 
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activate additional T-Lymphocytes, act as helper factors for B-cell 
proliferation, stimulate fibroblast to produce collagen and stimulate 
macrophage. 
Activated macrophages produce prostaglandin E2 and enzyme such 
as collagenase, elastase and cathepsin, TNF which may play a part 
in destruction of  bone and cartilage28. 
IL-1 and TNF have potent effects on synovial fibroblast and 
chondrocyte function that involve stimulation of prostaglandin and 
collangenase production as well as modulation of synthesis of 
proteoglycans, collagen and fibronectin.in organ culture both IL-1 
and TNF cause cartilage cells to resorb matrix. IL-1 Can also act 
on osteoblast to generate osteoclast activation28. 
Rheumatoid factor: 
         The immunological abnormalities in the serum of the patients 
include hypergammaglobulinemia and the presence of RF. IgG RF 
binds with its own Fc portion to form immune complex which are 
found in the synovial membrane and synovial fluid surrounding 
blood vessels.they are phagocytosed by neutrophils ,monocytes and 
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macrophages with release of number of enzymes and inflammatory 
mediators. 
     In addition to the  above, immune complex activate complement 
cascade which generate inflammatory and chemotactic factors with 
futher accumulation of inflammatory cells. 
     High RF titre correlate with the presence of severe erosive joint 
disease, nodules ,vasculitis,and extra articular complication of 
RA24. 
SIMPLIFIED DIAGRAM OF FOUR STEPS IN THE 
AETIOPATHOGENESIS OF RA23. 
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                                                   DIAGNOSIS 
The American college of Rheumatology (ACR)25 has developed and revised 
criteria for the classification of RA based on a hospital population of patients 
with established active disease. These criteria distinguish active RA from other 
forms of inflammatory arthritis with a diagnostic sensitivity and specificity of 
about 90%. 
Table:1 1987 REVISED AMERICAN RHEUMATISM ASSOCIATION 
CRITERIA FOR CLASSIFICATION OF RHEUMATOID ARTHRITIS25 
*  
Criterion Definition 
1. Morning 
stiffness 
Morning stiffness in and around the joints lasting at least 1 
hr before maximal improvement 
2. Arthritis of 
three or more joint 
areas 
At least three joint areas simultaneously having soft tissue 
swelling or fluid (not bony overgrowth alone) observed by 
a physician (the 14 possible joint areas are [right or left] 
PIP, MCP, wrist, elbow, knee, ankle, and MTP joints) 
3. Arthritis of 
hand joints 
At least one joint area swollen as above in wrist, MCP, or 
PIP joint 
4. Symmetric 
arthritis 
Simultaneous involvement of the same joint areas (as in 
criterion 2) on both sides of the body . 
5. Rheumatoid 
nodules 
Subcutaneous nodules over bony prominences or extensor 
surfaces, or in juxta-articular regions, observed by a 
physician 
6. Serum 
rheumatoid factor 
Demonstration of abnormal amounts of serum "rheumatoid 
factor" by any method that has been positive in less than 5 
percent of normal control subjects 
7. Radiographic 
changes 
Changes typical of RA on PA hand and wrist radiographs, 
which must include erosions or unequivocal bony 
decalcification localized to or most marked adjacent to the 
involved joints (osteoarthritis changes alone do not 
qualify) 
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First Four criteria for atleast 6 weeks duration.RA is defined by presence of four 
or more criteria. 
 
 CLINICAL FEATURES 
     RA is a systemic disorder characterized by a chronic inflammatory synovitis 
mainly the Di- Arthrodial joint34. 
¾ Prevalence and onset 
• More common in female sex. Majority have insidious onset of 
illness(70%). Other modes are 
 Acute                            15% 
 Oligo- articular             44% 
 Systemic                       10% 
 Polyarticular                  55% 
 Palindromic                   5% 
 Monoarticular               21% 
   Articular Manifestations: 
      RA is typically a distal symmetrical small joint polyarthritis involing the 
PIP and   MCP joints of the hands, wrist, MTP joints, ankles, knee and cervical 
spine.Any  Synovial joint including cricoarytenoid joint, tissue such as bursae 
and tendon sheath are inflammed55. 
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    The most common symptoms are pain and stiffness.The latter frequently 
exhibit diurnal rhythms, worse on early morning. The affected joints worse as 
the disease advances, muscle atrophy , tendon sheath and joint destruction 
results in limitation of joint movement, joint instability , subluxation and 
deformity. 
   Characteristic deformity include flexion contracture of  small joints of hands 
and feet, the knee, hips and elbow.Anterior subluxation of MCP joint is 
common with ulnar deviation of fingers .Others include swan neck deformity, 
Boutonniere deformity, plano key sign, carpel collapse and fusion,  Z –
deformity of thumb. 
     In the forefoot, subluxation of  MTP joint is followed by clawing of toes and 
callosities.Involment of knee is a common cause of  disability. Synovial 
effusion in posterior aspect leads of valve like mechanism and cyst formation 
and occasional ruptures.Tricompartmental articular damage leads to fixed 
flexion deformity,valgus deformity and total fusion55. 
    Axial involvement of cervical spine occurs in 8% .atlantoaxial subluxation 
upto 25% of patients. Subaxial subluxation present as a series risk of cord 
compression55. 
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¾ Extra articular features27: 
1.Rheumatoid nodules: 
     The commonest non-articular manifestation of RA is the 
granulomatous nodule which is characteristically found on the extensor 
aspect of forearm, elbow, scalp,scapula, sacrum and achiles tendon. 
Ulcerations and secondary infections are common. This can also occur in 
pleura. Lung parenchyma, pericardium, vocal cord and heart valves. 
Nodules are associated with positive test for RF27. 
2. Vasculitis: 
- Reynaud’s phenomenon can occur in the course of the disease.  
- Diffuse necrotizing vasculitis seen as nail fold infarcts, digital 
gangrene and purpura27. 
3. Pulmonary manifestations55: 
- Caplan syndrome consists of nodular opacities varying in size from 
0.5 to 5 cm throughout both lungs in a patient with RA.  
Others are, 
- Pleurisy 
- Pleural effusion 
- Pneumothorax 
- Fibrosing alveolitis 
- Nodules and cavitation 
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- Bronchiectasis 
- Obliterative bronchiolitis 
4. Cardiovascular manifestations: 
- Pericarditis occurs in less than 5% of cases. 
- Very rarely heart block, cardiomyopathy, aortic regurgitation and 
coronary artey occlusion occurs.  
5. Ocular features: 
- Keratoconjunctivitis sicca occurs in 10% of cases. 
- Episcleritis 
- Scleromalacia 
- Scleromalacia perforans 
6. Neurological manifestations: 
- Entrapment neuropathy of median nerve, ulnar nerve, peroneal nerve, 
posterior tibial nerve 
- Peripheral neuropathy 
- Vasculitis may lead to mono neuritis multiplex 
- Atlanto axial subluxation leads to cervical cord compression 
7. Musculo skeletal manifestation: 
- Osteoporosis, muscle weakness and wasting can occur adjacent to 
inflammed joints. 
8. Lymphatics: 
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- Lymphadenopathy is usually found in nodes draining the inflammed 
joints. The nodes are discrete and non tender. 
 
 
9. Renal: 
         Renal papillary necrosis and interstitial nephritis occur due to NSAID   
usage 
     Membranous glomerulo nephritis occur due to gold and d-penicillamine       
usage. 
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                         LIPID TRANSPORT AND METABOLISM. 
The major lipids are relatively insoluble in aqueous solutions and do not 
circulate in the free form. Free fatty acids are bound to albumin, whereas 
cholesterol, triglycerides, and phospholipids are transported in the form of 
lipoprotein complexes. The complexes greatly increase the solubility of the 
lipids. 
 There are six families of lipoproteins , which are graded in size and lipid 
content. The density of these lipoproteins (and consequently the speed at which 
they sediment in the ultracentrifuge) is inversely proportionate to their lipid 
content. In general, the lipoproteins consist of a hydrophobic core of 
triglycerides and cholesteryl esters surrounded by phospholipids and protein 
The way these lipoproteins are organized into an exogenous pathway, which 
transports lipids from the intestine to the liver, and an endogenous pathway, 
which transports lipids to and from the tissue33. 
The protein constituents of the lipoproteins are called apoproteins. The major 
apoproteins are called APO E, APO C, and APO B. There are two forms of 
APO B, a low-molecular-weight form called APO B-48, which is characteristic 
of the exogenous system   and a high-molecular-weight form called APO B-
100, which is characteristic of the endogenous system.  
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Table:2 Characteristics  of major classes of lipoproteins in the plasma.  
Lipoprotein Diameter(mm) Source Major 
Lipids 
Major 
apoproteins 
Density 
Chylomicrons 90 - 1000 Intestine Dietary 
triglyceride 
AI, AII , 
B48, CI, 
CII, CIII, E 
<0.95 
VLDL 30 - 90 Liver Endogenous 
triglyceride 
E, CI, CII, 
CIII, B100 
0.95 to 
1.006 
IDL 25 - 30 VLDL Cholesterol 
ester, 
triglyceride 
E, CIII, 
B100 
1.006 to 
1.019 
LDL 20 - 25 VLDL Cholesterol 
esters 
B100 ,  1.019 to 
1.063 
HDL 10 - 20 Liver, 
Intestine 
Cholesterol 
esters 
AI, AII 1.063 to 
1.125 
    Chylomicrons are formed in the intestinal mucosa during the absorption of 
the products of fat digestion . They are very large lipoprotein complexes that 
enter the circulation via the lymphatic ducts. After meals, there are so many of. 
these particles in the blood that the plasma may have a milky appearance. 
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 Table:3  ATP III61 Classification of LDL, Total and HDL Cholesterol and 
                                    Triglycerides (mg/dL) 
   Total cholesterol  
   <200 Desirable 
     200 - 239 Borderline High 
     ≥240 High 
  LDL cholesterol  
  <100 Optimal  
  100 - 129 Near or above optimal 
  130 - 159 Borderline high 
 160 - 189 High 
≥190 Very high 
 HDL cholesterol  
<40 Low 
  ≥60 High 
Triglyceride   
 <150  Near 
 150  - 199 Borderline high 
200 - 499 High 
≥500 Very high 
 
The chylomicrons are cleared from the circulation by the action of lipoprotein 
lipase, which is located on the surface of the endothelium of the Capillaries. The 
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enzyme catalyzes the breakdown of the triglyceride in the chylomicrons to FFA 
and glycerol, which then enter adipose cells and are reesterified. Alternatively, 
the FFA remain in the circulation bound to albumin. Lipoprotein lipase, which 
requires heparin as a cofactor, also removes triglycerides from circulating very 
low density lipoproteins (VLDL)33 . 
 Chylomicrons and VLDL contain APO C, a complex of proteins that separates 
from them in the capillaries. One component of the complex, apolipoprotein C-
II,activateslipoproteinlipase.  
 
Chylomicrons depleted of their triglyceride remain in the circulation as 
cholesterol-rich lipoproteins called chylomicron remnants, which are 30-80 nm 
in diameter. The remnants are carried to the liver, where they bind to 
chylomicron remnant and LDL receptors. They are immediately internalized by 
receptor-mediated endocytosis, and are degraded in lysosomes.  
 
The chylomicrons and their remnants constitute a transport system for ingested 
exogenous lipids . There is also an endogenous system made up of VLDL, 
intermediate-density lipoproteins (IDL), low-density lipoproteins (LDL), and 
high-density lipoproteins (HDL), which transports triglycerides and cholesterol 
throughout the body35.  
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VLDL are formed in the liver and transport triglycerides formed from fatty 
acids and carbohydrates in the liver to extrahepatic tissues. After their 
triglyceride is largely removed by the action of lipoprotein lipase, they become 
IDL. The IDL give up phospholipids and, through the action of the plasma 
enzyme lecithin-cholesterol acyltransferase (LCAT), pick up cholesteryl esters 
formed from cholesterol in the HDL. Some IDL are taken up by the liver. The 
remaining IDL then lose more triglyceride and protein, in the sinusoids of the 
liver, and become LDL. During this conversion, they lose APO E, but APO B-
100remains.  
 
LDL provide cholesterol to the tissues. The cholesterol is an essential 
constituent in cell membranes and is used by gland cells to make steroid 
hormones. In the liver and most extrahepatic tissues, LDL are taken up by 
receptor-mediated endocytosis in coated pit.. The receptors recognize the APO 
B-100 component of the LDL . They also bind APO E but do not bind APO-
B4833.  
The human LDL receptor is one member of a family of receptors specialized for 
transport of macromolecules into cells via endocytosis in clarthrin-coated pits. 
     LDL are also taken up by a lower-affinity system in the macrophages and 
some other cells. In addition, macrophages preferentially take up LDL that have 
 23 
 
been modified by oxidation. Oxidation can also occur in macrophages. Large 
doses of antioxidants such as vitamin E appear to slow the progress of 
atherosclerosis in experimental animals, but to date, results in humans have 
been disappointing. The LDL receptor on macrophages and related cells is 
called the scavenger receptor. It is different from the receptor on other cells and 
has a greater affinity for altered LDL. When the macrophages become 
overloaded with oxidized LDL, they become the "foam cells" that are seen in    
earlyatheroscleroticlesions33.  
 
     In the steady state, cholesterol leaves as well as enters cells. Cholesterol 
appears to leave cells via one of the ABC cassette proteins , and this cholesterol 
is taken up by HDL. These lipoproteins are synthesized in the liver and the 
intestine.  
     A separate HDL receptor has now been identified and cloned. It is found 
primarily in endocrine glands that make steroid hormones and in the liver. The 
HDL system transfers cholesterol to the liver, which is then excreted in the bile. 
In this way it lowers plasma cholesterol. 
         APO E is synthesized by cells in the brain, spleen, lung, adrenal, ovary, 
and kidney, as well as the liver. Its concentration is greatly increased in injured 
nerves, where it appears to play a role in nerve regeneration. The apolipoprotein 
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E gene is present in the general population in three alleles: APO-2, APO-3, and 
APO-4. APO-4 is less common than APO-2 and APO-3 but is overrepresented 
in patients with Alz-heimer's disease  and seems to predispose to this disease33. 
HYPERLIPOPROTEINEMIA 
A number of diseases cause elevations in the concentrations of one or more 
lipoprotein classes in the plasma. In general these abnormalities are detected by 
the finding of an elevated concentration of triglyceride or cholesterol in the 
fasting plasma, a condition called hyperlipidemia23. 
CLINICAL FEATURES OF  HYPERLIPIDEMIA23 
1. Coronary heart disese 
2. Peripheral vascular disese 
3. Lipid deposition in soft tissues 
• Tendon xanthoma 
• Palmar xanthoma 
• Xanthelasma 
• Eruptive xanthoma 
• Corneal arcus 
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4. Lipemia retinalis 
5. Acute pancreatitis 
CLASSIFICATION: 
Hyperlipedemia can be classified into  
1. Primary – due to hereditary defects in lipoprotein metabolism 
2. Secondary – manifestation of some other conditions 
Table:4 Primary hyperlipidemia 
Genetic disorder Biochemical defects Lipoprotein elevation 
Familial lipoprotein 
lipase deficiency 
Deficiency of  
lipoprotein lipase 
Chylomicrons 
Familial apoprotein – CII 
deficiency 
Deficiency of apoprotein 
– CII 
Chylomicrons, VLDL 
Familial type III hyper 
lipoprotenemia 
Abnormal apo – E of 
VLDL 
Chylomicrons remnants 
& ILDL 
 Familial 
Hypercholesterolemia 
Deficiency of LDL 
receptor 
LDL 
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Familial Hyper 
triglyeridemia 
Unknown VLDL 
Secondary Hyperlipedemia 
Common causes are23 
1. Diabetes 
2. Hypothyroidism 
3. Alcohol consumption 
4. Collagen disorder 
5. CRF 
6. Nephrotic syndrome 
LABORARTORY EVIDENCE: 
As a working rule, hyperlipoprotenemia is considered to be present 
1. When the plasma cholesterol exceeds 200mg/dl 
2. When the triglycerides level exceeds 200mg/dl 
HYPO LIPOPROTENEMIA 
Hypolipoprotenemis is considered when the total cholesterol concentration is 
less than 100mg/dl 
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Hypo lipoprotenemia is either due to 
1. Hereditary triad ( rare) 
2. Secondary to number of diseases 
Hypo beta lipoprotenemia23 
Due to mutations in the gene for apo B 100. That disturbs the synthesis or 
produces truncated form of apo – B 100. 
Characterized by very low cholesterol and triglyceride level. 
CLINICAL FEATURES: 
Malabsorption of fat 
Ataxia 
Neuropathy 
Retinitis pigmentosa 
Acantho cytosis 
Treated with vitamin E 
SECONDARY HYPO LIPOPROTENEMIA23 
Common causes are 
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1. Malnutrition associated with – low total cholesterol 
2. Alcoholism & GI tract diseases- low LDL 
3. Hyper thyroidism – low total cholesterol 
4. Uncontrolled AIDS – low total cholesterol 
5. Acute & chronic myeloid leukemia – low LDL 
6. Gauchers and Niemann pick’s disease – low LDL & HDL. 
 
 
LIPID ABNORMALITIES IN ACTIVE RHEUMATOID ARTHRITIS 
Patient with active rheumatoid arthritis exhibit various lipid 
abnormalities, when compared with controls, the common abnormalities 
are17,20,38,41,54, 
1. Decreased serum lipid level 
2. Decreased total cholesterol level 
3. Decreased LDL cholesterol level 
4. Decreased HDL cholesterol level 
5. Decreased Triglyceride level 
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6. Elevated lipoprotein (a) level 
 
 
EXPLANATION FOR DYSLIPOPROTENEMIA IN RHEMATOID 
ARTHRITIS 
1. The reduction of Total cholesterol in active RA is due to reduced 
synthesis and increased clearance through scavenger receptor 
pathway38 
2. Oxidative modification of LDL is also important and is of special 
interest, that the product of LDL oxidation may be recognized by the 
scavenger receptor, leading to the increased uptake of modified 
lipoprotein particles by macrophages. They may be directly cytotoxic 
to endothelial cells, chemotactic for inflammatory cells and causes 
functional changes in smooth muscles. The inflammatory environment 
and disturbed anti oxidant mechanism in RA may promote LDL 
cholesterol oxidation, thereby facilitating atherogenesis at low 
lipoprotein concentration. Use of anti oxidants may lower the 
cardiovascular mortality.44 
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3. The presence of circulating anti oxidized LDL antibodies in RA, may 
be responsible for the reduced level of total cholesterol and LDL 
cholesterol.48 
4. Increased Cholesterol ester transfer protein (CETP)  activity is 
associated with low HDL-C levels in RA patients.36  
5. The reduced HDL-C level in RA patient compared to controls may be 
due to physical inactivity in RA patients.37 
 
VARIOUS STUDIES ON LIPID PROFILE IN RHEUMATOID 
ARTHRITIS PATIENTS. 
1.Lipid profile in Rheumatoid arthritis and its relation to disease 
activities43 
By vottery R, saigal R, singhal N, Gupta Bs. 
Department of medicine, SMS hospital, Jaipur 
Lipid profiles of 25 rheumatoid arthritis cases were compared with age and sex 
matched controls. Serum triglyceride & total cholesterol were found to be 
significantly lowered in RA patients, while serum LDL & HDL cholesterol 
were not altered significantly.43 
 31 
 
-JAPI 2001 Dec: 49:1188 - 90 
2.Dyslipoprotenemia in the course of active rheumatoid arthritis20 
-By Lazarevic MB, vatic J, M iadenovic V, Myones bl, skosey JL, swedler WL. 
Department of medicine, University of Illinois, Chicago 
Concentration of serum lipids and serum LDL were measured, and agarose gel 
electrophoresis of serum lipoprotein were performed in 69 persons of RA and 
65 healthy blood donors. RA patients had significantly decreased concentration 
of total serum lipids & serum cholesterol, LDL & HDL. Compared with healthy 
blood donors, RA patients with severe disease activity has significantly reduced 
cholesterol in LDL & HDL, compared with patients with minimal disease 
activity.20 
- Semin arthritis Rheum 1992 Dec; 22(3); 172-8 
3.Hypocholesterolemia & abnormal high density lipoprotein in rheumatoid 
arthritis18 
-By Lorber M, Aviram M, Linn S, Scharf Y, Brook JG. 
Plasma lipids & lipoprotein patterns were determined in 54 female RA patients. 
 There was 26% reduction in total cholesterol, 36% reduction in both LDL & 
HDL were observed. Plasma apo A – 1, the major HDL protein was in the 
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normal range suggesting an abnormal HDL fraction, even though reduced HDL 
was found in RA patient, HDL/LDL ratio was normal and apo A 1/ apo – B 
ratio was increased, suggesting that these patients are at increased risk of 
atherosclerosis.18 
- Br j Rheumatol 1985 Aug: 24(3);250-5 
4.Serum total, HDL, LDL, cholesterol and triglycerides levels in  patients 
with rheumatoid arthritis40. 
-By Lakatos J, Harsagyi A, United sanitary institution, pecs, Hungary. 
In this study, patients with rheumatoid arthritis ( 26 men, 103 women ) the 
serum total cholesterol, HDL cholesterol & triglycerides were lowered when 
compared to controls. (625 men & 749 women).40 
5.Serum lipoprotein in active Rheumatoid arthritis and other chronic 
inflammatory arthritis. Relativity to inflammatory activity38. 
-By svenson KL,Lithell H, Hallgren R, Selinus I,Vessby B. 
Department of internal medicine, University hospital, Uppasala, Sweeden 
Lipid metabolism was found in 69 patients with untreated rheumatoid arthritis 
(48) and in sero negative spondylo arthropathies. (21). The patients had high 
inflammatory activity as measured by ESR & CRP. Serum cholesterol and 
cholesterol levels in VLDL, LDL & HDL were reduced by 20% to 30%. The 
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triglyceride level in VLDL & HDL were reduced by 10% to 30% compared to 
healthy controls.38 
There was significant correlation between the inflammatory activity and certain 
lipoprotein level 
-Arch Intern Med .1987 Nov;147(11); 1912-6 
 
6.lipoprotein (a), lipids and lipoproteins in patients with rheumatoid 
arthritis41 
-By Rantapaa – Dahlgvist S, Wallberg – Jonsson S, Dahlen G. 
Department of rheumatology, university hospital, Umea, Sweeden 
Lipoprotein (a), an independent atherogenic factor was significantly increased 
in 93 patients with sero positive RA. The plasma concentration of cholesterol & 
HDL in both male & female patients were lower than in controls.41 
-Ann Rheum Dis 1991 Jun, 50(6) ; 366-8 
 
7.Dyslipidemia & rheumatoid arthritis37 
-By Munro R, Morrison E, Mc Donald AG. 
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The inflammatory environment and disturbed anti oxidant mechanism in 
rheumatoid arthritis may promote LDL oxidation, thereby facilitating 
atherogenesis.37 
 
8.serum oxidized low density lipoprotein in RA58 
-By Kim SH, Lee CK, Lee EY, park SY, Choys, Yoo B. 
Division of allergy & rheumatology, Department of medicine, University of 
Ulsan college of medicine, Orsan medical centre, Seoul, Korea. 
Compared with healthy women, those with active RA, had increased serum 
oxidized LDL level, which may contribute to the increased risk of 
cardiovascular diseases in these group of patients.58 
-Rheumatol Int. 2003 Nov 20 
9.Increased level of anti oxidant LDL antibodies are associated with 
reduced level of cholesterol in general population59. 
-By Tinahones FJ, Gomez – Zumaquero JM, Cardona F. 
Carlos Haya, regional hospital, Malaga, Spain. 
This study shows the relationship between the level of auto antibodies to 
oxidized LDL & lipoprotein in a population of 400 patients. Anti oxidized LDL 
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antibodies were measured by ELISA and total cholesterol, triglyceride, HDL 
were measured by commercial kits. Subjects who were positive for anti 
oxidized LDL antibodies had significantly lowered level of total cholesterol & 
LDL cholesterol.59 
-Metabolism. 2002 Apr, 51(4); 429-31 
 
 
10.Effect of anti rheumatic therapy on serum lipid levels in patients with 
RA39. 
-By Park YB, Choi HK, Kim MY, Lee WK , Song J. 
Division of rhuematology, Dept. Of medicine, Yonsei university college of 
medicine, Seoul, Korea. 
Active rheumatoid arthritis is associated with adverse lipid profile that improves 
following effective treatment of RA. This improvement may reduce the risk of 
cardiovascular disease.39 
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                                  MATERIALS & METHODS 
SETTINGS:    Patients  attending Rheumatology outpatient department, 
Madras Medical  College and Government general hospital Chennai - 600 003. 
 ETHICAL APPROVAL: 
                              Obtained  
STUDY DESIGN: 
          To Study the lipid profile abnormalities in rheumatoid arthritis patients , 
and the correlation between lipid abnormalities and severity of the disease 
 a cross sectional study design was chosen. 
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PERIOD OF STUDY: 
          January 2008 to September 2008 
SAMPLE SIZE 
 Cases: 50, Controls: 50 . 
 
 
INCLUSION CRITERIA: 
1. Arthritis of hand joints: 
2. Soft tissue swelling of 3 or more than 3 joints 
3. Morning stiffness for atleast one hour. 
4. Symmetrical arthritis 
5. Positive rheumatoid factor 
EXCLUSION CRITERIA: 
1. Patients with rheumatoid arthritis with the following conditions were 
excluded from the study 
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1. Malabsorption syndrome 
2. Nephrotic syndrome 
3. Diabetes mellitus 
4. Thyroid disorders 
5. Liver disorders 
6. Intake drugs like 
a. Diuretics 
b. Oral contraceptives 
7. Lipid storage disorders 
STUDY POPULATION: 
                 Fifty  patients  of  Rheumatoid  arthritis  and  fifty  age  
and  sex matched healthy  controls were  selected  for  the  study 
from   Rheumatology      clinic  and  outpatient  department  of  
Institute  of  Internal  Medicine,  Government  General  hospital 
Chennai, after thorough history taking and clinical examination 
and by exclusion criteria..  
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            All the RA patients were selected on the basis of 1987 revised criteria of 
American rheumatism Association for the classification of rheumatoid arthritis. 
Fifty patients with the age group ranging from 20 to 70 years were studied, they 
were at different stages of rheumatoid arthritis. 
Age & sex matched healthy persons, between the age of 20 to 70 years were 
taken for the control study. 
LABAROTARY MEASUREMENTS 
In all the cases latex fixation test for rheumatoid factor was done. 
After ensuring 12 hours overnight fasting, normal diet ( without any fat 
restriction) for previous two weeks, and abstinence from alcohol, the blood 
samples were collected from RA patients & healthy controls. From the blood, 
serum was separated & stored in refrigerator. Then this was used for lipoprotein 
analytical studies. 
Concentration of total cholesterol, HDL-cholesterol, and triglycerides 
were assessed enzymatically with commercially available reagents. 
Concentration of LDL- cholesterol was calculated by use of the Friedewald 
equation for participants who had triglycerides (< 400 mg/dl)    
                                  LDL = TC ─ HDL-c ─ TGL/5. 
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The marker of inflammation like ESR was measured by Wintrobe’s method. 
FINANCIAL SUPPORT: nil. 
CONFLICT OF INTEREST: nil. 
 
 
 
 
 
 
      STATISTICAL ANALYSIS 
Statistical  analysis  was  carried  out  for  100  participants  [50  RA 
patients, 50 controls] after categorizing each variable. Base line data was 
collected  from  patients  Age,  sex,  duration  of  early  morning 
stiffness,Lipid profile, ESR were analyzed.  
The  significance of difference  in mean between  two groups were 
analyzed by    student  t‐test. The  correlation between Lipid profile  and 
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ESR, early morning stiffness calculated by   using the Pearson's correlation 
coefficient method.  
Statistical  significance was  taken when p value  <  0.05.  Statistical 
analysis was carried out using standard  formulae. Microsoft excel 2007 
and SPSS (statistical package for social sciences) version 13 software was 
used for data entry and analysis. 
                                                     
 
                                  RESULTS  AND  OBSERVATION 
  In our study , 50 RA patients matched with 50 healthy controls were studied 
for lipid abnormalities and the following observation were made. Patients with 
age group ranging from 20 to 70 years were studied. 
                          Table:5    AGE DISTRIBUTION IN  THIS STUDY 
    AGE IN YEARS    NUMBER OF 
PATIENTS 
   PERCENTAGE 
            % 
    20 - 30                     15             30% 
    31 - 40                      14             28% 
    41 - 50                        9             18% 
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    51 - 60                        9             18% 
    61 - 70                        3                6% 
In this study, Rheumatoid arthritis diseased patients lies more in the age group 
of 20 to 40 years. 
 
                                Table:6  SEX DISTRIBUTION IN  THIS STUDY 
                       SEX    NUMBER OF 
PATIENTS 
   PERCENTAGE 
 
                   FEMALE                   43                        86% 
                   MALE                     7                         14% 
This study shows females are affected more than males. 
 
Table:7 LIPID PROFILE IN STUDY GROUP –STATISTICAL 
ANALYSIS 
 TC(mgs/dl) LDL(mgs/dl) TGL(mgs/dl) HDL(mgs/DL) TC/HDL 
Ratio 
MEAN     158.64       96 148.68     32.32 4.96 
MEAN 
DEVIATION 
    8.12       7.84 14.88     3.28 0.49 
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STANDARD 
DEVIATION 
    9.59       9.15 17.7     3.96 0.59 
STANDARD 
ERROR OF 
MEAN 
    1.36       1.29 2.50     0.56 0.08 
STANDARD 
ERROR OF 
DIFFERENCE  
BETWEEN 
THE TWO 
MEAN 
    2.78       2.88 3.06     0.93 0.16 
 
 
 
 
Table:8 LIPID PROFILE IN CONTROL  GROUP –STATISTICAL    
ANALYSIS 
 TC(mgs/dl LDL(mgs/dl TGL(mgs/dl HDL(mgs/DL) TC/HDL 
Ratio 
MEAN     172.6       106.5 166.32     32.46 5.45 
MEAN 
DEVIATION 
    13.59       9.33 9.30     4.19 0.79 
STANDARD 
DEVIATION 
    17.18       18.20 12.43     5.24 0.97 
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STANDARD 
ERROR OF 
MEAN 
    2.43       2.57 1.76     0.74 0.14 
      
   Table: 9 COMPARISION OF STUDY AND CONTROL GROUP  
MEAN 
 TC(mgs/dl) LDL(mgs/dl) TGL(mgs/dl) HDL(mgs/DL) TC/HDL 
Ratio 
STANDARD 
ERROR OF 
DIFFERENCE  
BETWEEN 
THE TWO 
MEAN 
   
 
2.78 
 
 
 
   2.88 
 
 
3.06 
  
 
0.93 
 
 
0.16 
t-TEST 
VALUE 
-5.017  -3.645  -5.767  -0.151 -3.052 
P” VALUE <0.0001 0.0004 <0.0001 0.8806  0.0029 
In this study TC, LDL-C, TGL ,TC/HDL are significantly reduced and 
HDL-C not significantly reduced. 
Table:10 COMPARISION OF LIPID VALUES IN STUDY AND CONTROL 
GROUPS 
GROUP  TC(mgs%)     LDL TGL  HDL TC/HDL 
STUDY  158±9.59 96±9.15 148.7±17.7  32.3±3.96 4.96±0.59
CONTROL  172.6±17.2 106.5±18.2 166.3±12.4  32.5±5.24 5.45±0.97
 45 
 
This study shows reduced TC, LDL-C, TGL, TC/HDL  , when compared to 
controls. 
 
 
Table:11  COMPARATIVE  ANALYSIS  OF  LIPID      DISORDER 
       NO. OF PATIENT            PERCENTAGE TYPE OF LIPID 
DISORDER 
STUDY CONTROL STUDY CONTROL
TC>200     0       2     0%       4% 
LDL>130     0       4     0%       8% 
TGL>150     21     44     42%     88%   
HDL<40 
         >40 
    48 
      2 
    44 
       6 
    56% 
      4% 
    88% 
    12% 
TC/HDL  >6       3     17       6%     34% 
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             Table: 12  E.S.R. LEVEL – AN ANALYSIS IN THIS STUDY 
   ESR LEVEL(mm/hr)    NO. OF PATIENTS PERCENTAGE  % 
   <40                        4                   8% 
   41 - 60                      10                20% 
   61 - 80                      15                30% 
   >80                      21                42% 
Increased ESR >80 mm/hr found in 42% of RA patients. 
Figure: 13 COMPARISION OF ESR BETWEEN STUDY AND CONTROL 
GROUP 
    GROUP MEAN±SD 
OF ESR 
STANDARD 
ERROR OF 
DIFFERENCE 
BETWEEN 
TWO MEAN 
  t-TEST   P VALUE 
   STUDY 74.52±19.9 
  CONTROL 11.96±4.7 
 
2.89 
 
21.64 
 
<0.0001 
        ESR is significantly raised in RA patients when compared to controls. 
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     Table:14 MORNING STIFFNESS DISTRIBUTION IN STUDY 
GROUP 
MORNING 
STIFFNESS(min) 
NO. OF PATIENTS PERCENTAGE  % 
      <30 min                5      10% 
       31 – 60 min                30      60% 
       >60 min                15      30% 
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Table:15 CORRELATION BETWEEN AGE AND TOTAL     
CHOLESTEROL LEVEL 
 <100 mgs% 101 – 150 
mgs% 
151 – 200 
mgs% 
 >200 mgs% AGE(YEARS) 
controls cases controls cases controls cases controls cases
20 - 40     0   0   4   8   26   21   2   0 
41 - 60   0   0   2   2   13   16   0   0 
 >60   0   0   0   0     3     3   0   0 
 
In the study group,  TC levels in 40 patients  were in the  range of  151- 200 
mgs% , out of which 21 patients  lie in the age group of 20 to 40 years. 
 
 
 
 
Table:16 CORRELATION BETWEEN SEX AND TOTAL 
CHOLESTEROL LEVEL 
 <100 mgs% 101 – 150 
mgs% 
151 – 200 
mgs% 
 >200 mgs%       SEX 
controls cases controls cases controls cases controls cases 
FEMALE   -   -   6   9   35   34   2   - 
MALE   -   -   1   1     6   6   -   - 
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Table:17 CORRELATION BETWEEN AGE AND LDL     
CHOLESTEROL LEVEL 
 <60 mgs% 61 – 80 mgs% 81 – 100 mgs%  >100 mgs% AGE(YEARS) 
controls cases controls cases controls cases controls cases
20 - 40   0   0   4   4   4   20   24   5 
41 - 60   0   0   0   1   6   10   9   7 
 >60   0   0   0   0   1     2   2   1 
 
In the study group,  LDL-C level  in 13 patients  was >100 mgs% , out of which 
7 patients lies in the age group of 41 to 60 years. 
 
 
 
 
Table: 18 CORRELATION BETWEEN SEX AND  LDL   
CHOLESTEROL LEVEL 
 <60 mgs% 61 – 80 mgs% 81 – 100 mgs%  >100 mgs%       SEX 
controls cases controls cases controls cases controls cases 
FEMALE   -   -   4   5   10   28   29   10 
MALE   -   -   -   -     1   4      6   3 
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Table:19 CORRELATION BETWEEN AGE AND 
TRIGLYCERIDE LEVEL 
 <100 mgs% 101 – 140 
mgs% 
141 – 180 
mgs% 
 >180 mgs% AGE(YEARS) 
controls cases controls cases controls cases controls cases
20 - 40   0   0   2   9   27   20   3   0 
41 - 60   0   0   0   7   14   11   1   0 
 >60   0   0   0   0   2     3   1   0 
 
In the study group,  TGL level  in 34 patients  were in the  range of  141- 180 
mgs% , out of which 20 patients lies in the age group of 20 to 40 years. 
 
 
 
 
Table:20  CORRELATION BETWEEN SEX AND    
TRIGLYCERIDE LEVEL 
 <100 mgs% 101 – 140 
mgs% 
141 – 180 
mgs% 
 >180 mgs%       SEX 
controls cases controls cases controls cases controls cases 
FEMALE   -   -   2   15   38   28   3   - 
MALE   -   -   -     1     5     6   2   - 
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Table:21 CORRELATION BETWEEN AGE AND HDL CHOLESTEROL 
LEVEL  TC/HDL RATIO 
HDL<30 mgs% HDL 31 - 35 
mgs% 
HDL 36 – 40 
mgs% 
HDL >40 
mgs% 
TC /HDL >6       
AGE(YEARS 
controls cases controls cases controls cases controls cases controls cases 
20 - 40   12   10   7   10   9   9   4   0   10   3 
41 - 60   8     6   5     8   2   3   0   1   6   0 
>60     1     3   2     0   0   0   0   0   1   0 
 
In the study group, only one patient  had  HDL-C >40 mgs%.and 3 patients had 
TC/HDL>6. 
 
 
Table:22 CORRELATION BETWEEN SEX AND HDL CHOLESTEROL 
LEVEL  TC/HDL RATIO 
HDL<30 
mgs% 
HDL 31 - 35 
mgs% 
HDL 36 – 40 
mgs% 
HDL >40 
mgs% 
TC /HDL >6     SEX 
controls cases controls cases controls cases controls cases controls cases
FEMALE  
   20 
 
  15 
 
    9 
 
  16 
 
    10 
 
11 
 
   4 
 
  1 
 
      16 
 
  3 
MALE    1     4        5     2       1  1     -     -       1     -  
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Table:23 CORRELATION BETWEEN LIPID ABNORMALITY AND    
ESR 
 
ESR(mm/hr)  TOTAL 
NO. OF 
PATIENT 
TC(mgs%) LDL(mgs%) TGL(mgs%) HDL(mgs%) TC/HDL
20 - 40    4   171±3.82 105± 3.7 158 ±16.8 34± 1.4 5± 0.21 
41 - 60    10   
168.3±5.9 
102 ±5.2 156.5± 12.4 34.3± 2.2 4.9± 
0.37 
61 - 80    15   
156.4±8.6 
92.5± 9.7 155± 15.8 32.5± 5.2 4.9±  
0.74 
  >80    21   153.3±7 93.8±  8.6 138.7± 17.9 30.9± 3.6 5 ±0.62 
   
 This study shows negative correlation between ESR and lipids . 
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 Table:24  CORRELATION BETWEEN LIPID ABNORMALITY AND 
EARLY MORNING STIFFNESS 
 
EARLY 
MORNING 
STIFFNESS 
 TOTAL 
NO. OF 
PATIENT 
TC(mgs%) LDL(mgs%) TGL(mgs%) HDL(mgs%) TC/HDL
≤30 min     5 164.4 
±14.6 
100± 10.9 166.4± 10 33.2± 5.2 5.1± 
0.91 
31 – 60 min   30 152.3± 
17.3 
95.7± 8.5 158.5± 9.1 32.8± 4 4.9 
±0.54 
>60 min   15 136.3± 
13.1 
96.8± 9.9 156.3±  9.9 31.1 ±3.6 5.1± 
0.59 
 
  This study, shows that TC and TGL cholesterols  negatively correlate 
significantly with duration of early morning stiffness in RA 
patients.Whereas LDL-C, HDL-C are negatively correlating 
insignificantly with duration of early morning stiffness. 
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                                               DISCUSSION 
     The complete analysis of 50 Rheumatoid arthritis patients were done. The 50 
age & sex matched health persons were taken as controls. 
     They were studied on the basis of clinical features, biochemical features, 
radiological features with special reference to lipid profile. Some characteristic 
features noted in the study are given below. 
      In this study out of 50 cases, 43 were females, 7 were males. The female to 
male ratio was 6.14:1. 
    The age of the patient ranged from 20 to 70 years with mean age 40.38±12.64 
in study group and 40.04±11.7 in control group.  
    All the 50 patients (100%) fulfilled the revised criteria of American 
Rheumatism Association for Rheumatoid arthritis25. 
LIPID PROFILE ABNORMALITIES IN RHEUMATOID ARTHRITIS: 
PATIENTS & CONTROLS 
TOTAL CHOLESTEROL: 
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Total cholesterol was significantly reduced in rheumatoid arthritis patients, 
when compared to controls. The total cholesterol levels in our patients was 
158.64± 9.59. In controls, the level was 172.6± 17.18.(p value of <0.0001) 
LDL cholesterol: 
LDL cholesterol was significantly reduced in RA patients, when compared to 
controls. In our patients, LDL-C level was 96± 9.14. In control, the level was 
106.5 ± 18.20 ( p value < 0.0004) 
TRIGLYCERIDES: 
Triglyceride level was also significantly reduced in RA patients, when 
compared to controls. In our patients, the triglyceride level was 148.68± 17.7. In 
controls, it was 166.32±  12.43. ( p value < 0.0001) 
HDL CHOLESTEROL 
In our study, HDL-C cholesterol was not significantly reduced, when compared 
to controls. In our study, it was 32.32± 3.96. In controls, it was 32.46± 5.24.( p 
value is  0.8806) 
TC/HDL LEVEL: 
In our study, TC/HDL level was significantly reduced when compared to 
controls. In our patients, it was 4.96± 0.59. In controls, it was 5.45± 0.97 ( p = 
0.0029) 
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    Thus from this study, serum total cholesterol, LDL cholesterol & triglyceride 
were significantly lower in RA patients, as compared to controls, while serum 
HDL cholesterol was not significantly altered in RA patients. TC/HDL ratio 
was also significantly reduced. 
CORRELATION WITH AGE: 
  In our study, out of 50 Rheumatoid arthritis patients, 29 patients were in the 
age group of 20 to 40 years. 
¾ Total cholesterol in eight patients were in the range of 101 to 150 mg% 
and in  21 patients were in the range 151 to 200 mg% . 
¾  LDL –C in  four patients were in the range of 61 to 80mg% , 20 patients 
were in the range of 81 to 100mg% and in 5 patients were above 100mg%  
¾     TGL in nine patients were in the range 101 to 140mg% and  20 patients 
were in the range of 140 to 180mg% . No patients had  above 180 mg% 
of TGL. 
¾ HDL-C in ten patients were below 30mg% , 10 patients were in the range 
of 31 to 35mg% and in  9 patients were in the range of 36 to 40 mg%. No 
patient had above 40mg%.  
¾ The  TC/HDL ratio in three patients were above 6. 
OUT OF 18 PATIENTS IN THE AGE GROUP OF 41 TO 60 YEARS 
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¾ TC in two patients were in the range of 101 to 150 mg% ,and in 16 
patients were in the range of 151 to 200 mg% . 
¾ LDL-C in one patient was in the range of 61 to 80mg% , 10 patients were 
in the range of 81 to 100mg%  and in  7 patients were above 100 mg%  . 
¾ TGL  in seven patients were in the range of 101 to 140 mg% .and in 11 
patients were in the range of 141 to 180 mg% . 
¾ HDL-C  in six patients were below 30mg% , 8 patients were between 31 
to 35 mg%  and 3 patients were in the range of 36 to 40 mg% . One 
patient had above 40mg%. 
¾ No patient was above 6 in TC/HDL ratio. 
  Out of three patients, above 60 years. 
¾ TC in 3 patients were in the range of 151 to 200 mg%.  LDL-C in  2 
patients were in the range of 81 to 100 mg% and in one patient was more 
than 100mg% . 
¾ TGL in three patients were in the range of 141 to 180mg% . 
¾ HDL-C in three patients were below 30mg% . 
¾ TC/HDL ratio above 6 was not found in this age group. 
 
CORRELATION WITH SEX: 
¾  In this study of 50 RA patients 43  were female patients & 7 were  male 
patients. 
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¾ TC in nine female patients were in the range of 101 to 150mg%, one male 
patient was in the range of 101 to 150mg% ,34 female patients and in  
six male patients were in the range of 151 to 200 mg% . 
¾  LDL-C  in five female patients were in the range of 61 to 80mg%. 29 
female patients & 4 male were in the range of 81 to 100mg% . 10 female 
patients and in  3 male were above 100mg% . 
¾ TGL  in fifteen female patients and in  one male patient were in the range 
of 101 to 140mg%. 28 female and in  6 male patients were in the range 
of 141 to 180mg% . 
¾  HDL-C in  fifteen female and in 4 male patients were  below 30mg%. 16 
female and in  2 male patients were in the range of 31 to 35 mg% . 11 
Females and in 1 male patient were in the range of 36 to 40mg% . HDL-
C in one  female patient was more than 40mg%. 
¾ TC/HDL ratio  in three female patients were more than 6. 
 
CORRELATION WITH ESR: 
¾ In this study, 4 patients had ESR less than 40mm/hr, with  TC  171±  
3.82, LDL-C  105± 3.7, TGL  158 ± 16.8, HDL-C  34 ±  1.4 and 
TC/HDL was 5± 0.21. 
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¾ The ESR in ten patients was  between 41 to 60 mm/hr, with TC  168.3± 
5.9, LDL-C 102 ±5.2, TGL 156.5± 12.4, HDL-C  34.3± 2.2 and 
TC/HDL ratio was 4.9± 0.37. 
¾ The  ESR in fifteen patients was between 61 to 80 mm/hr, with TC  
156.4± 8.6, LDL-C  92.5± 9.7, TGL  155 ±15.8, HDL-C  32.5± 5.2 and 
TC/HDL was 4.9± 0.74. 
¾ The  ESR in twenty one patients was  more than 80 mm/hr, with TC  
153.3 ±7, LDL-C  93.8± 8.6, TGL  138.7 ±17.9, HDL-C  30.9± 3.6 and 
TC/HDL was 5± 0.62. 
In our study Pearson correlation between ESR and lipids shows 
 Inverse correlation of ESR with TC (r=-0.701 ,p<0.0001 ) 
 Inverse correlation of ESR with LDL-c  (r= -0.436 , p=0.0015 ) 
 Inverse correlation of ESR with TGL  (r= -0.454  ,p= 0.0009 ) 
  Inverse correlation of ESR with HDL  (r= -0.388  ,p= 0.0054 ) 
¾ From this study, it can be concluded that, in RA patients lipid profile 
abnormalities is  negatively correlated significantly with ESR.  
 CORRELATION WITH EARLY MORNING STIFFNESS: 
¾ In this study, 5 patients had early morning stiffness of less than 30 min., 
with total cholesterol was 164.4 ± 14.6, LDL-C was 100± 10.9, TGL was 
166.4 ±10, HDL-C was 33.2± 5.2 & TC/HDL ratio was 5.1± 0.91.  
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¾ Thirty patients had early morning stiffness of between 31 to 60 min., with 
total cholesterol was 152.3 ±17.3, LDL-C  was 95.7± 8.5, TGL was 
158.5± 9.1, HDL-C was 32.8± 4 & TC/HDL ratio was 4.9± 0.54. 
¾  Early morning stiffness of more than 60 min in  fifteen patients., with 
total cholesterol was 136.3 ±13.1, LDL-C was 96.8± 9.9, TGL was 
156.3± 9.1, HDL-C was 31.1± 3.6 & TC/HDL ratio was 5.1± 0.59 
In our study Pearson correlation between Early morning stiffness and lipids 
shows 
 Inverse  correlation of TC with Morning stiffness (r= -0.337, p= 
0.0166) 
 Inverse  correlation of LDL with Morning stiffness (r= -0.103 , p= 
0.4746) 
 Inverse  correlation of TGL with Morning stiffness (r= -0.509 , 
p=0.0002) 
 Inverse  correlation of HDL with Morning stiffness (r= -0.211 , 
p=0.1419) 
 
    From this study, it can be concluded that TC and TGL cholesterols  
negatively correlate significantly with duration of early morning stiffness 
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in RA patients.Whereas LDL-C, HDL-C are negatively correlating 
insignificantly with duration of early morning stiffness. 
COMPARISION OF PREVIOUS STUDIES  WITH PRESENT 
STUDY 
 
Table:25 COMPARISION OF GEORGIADIS et al36 WITH 
PRESENT STUDY 
   LIPID                  PRESENT STUDY          GEORGIADIS et al 
 STUDY CONTROL     P 
Value 
STUDY CONTROL     P 
value 
TC(mean±SD) 158.64 ±  
9.59 
 
172.6±17.18 0.0001 216±50.3 296.4 
<0.001 
TGL(mean±SD) 148.68±17.7 166.32±12.43 0.0001 133± 
58.2  
69.6 <0.001 
HDL(mean±SD) 32.32±3.96 32.46±5.24 0.8803 47.5± 
11.8 
63.6 <0.001 
LDL(mean±SD) 96±9.15 106.5±18.20 0.0004 141±42.3 126.5±31.3 <0.001 
TC/HDL 4.96 ±0.59 5.45±0.97 0.0029 4.9±1.3 3.7±0.9 <0.001
 
    IN  GEORGIADIS et al36 study significantly raised TC,LDL, TGL, , 
TC/HDL with reduced HDL. TC and HDL are negatively correlated 
significantly  with CRP and ESR. Increased CETP activity is found in RA 
patients with  low HDL-C levels. 
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   In our study, TC,LDL, TGL ,TC/HDL are significantly reduced with 
insignificant reduction in HDL levels in RA compare to controls. A significant 
negative  correlation is present between all lipid parameters and ESR. 
Table:26 COMPARISION OF VEIL COBANKARA et al 57WITH 
PRESENT STUDY 
                 PRESENT STUDY     VEIL COBANKARA et al    LIPID 
STUDY CONTROL     P  
Value 
STUDY CONTROL     P  
Value 
TC 
(mean±SD) 
158.64 ±   
9.59 
 
172.6±17.18 0.0001 188.4±41.8 185±19.3 NS 
LDL 
(mean±SD) 
96±9.15 106.5±18.20 0.0004 123.4±24.6 113.3±21.1 NS 
TGL 
(mean±SD) 
148.68±17.7 166.32±12.43 0.0001 124.5±50.1 94.6±24.9 <0.001
HDL 
(mean±SD) 
32.32±3.96 32.46±5.24 0.8803 40±7.4 52.8±4.8 <0.001
TC/HDL 4.96 ±0.59 5.45±0.97 0.0029 4.7±1.5 3.5±0.7 <0.01 
 
In VEIL COBANKARA et al57 study, significantly reduced HDL, increased 
TGL were found. TC, and LDL were insignificantly raised when compared to 
controls.Lipoprotein(a) significantly raised. 
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      Table:27  COMPARISION OF ASANUMA et al56 WITH PRESENT 
STUDY 
                       PRESENT STUDY       ASANUMA et al56      LIPID 
STUDY  CONTROL         P  
Value 
STUDY  CONTROL  P  Value 
TC (mean±SD)  158.64 ±   
9.59 
 
172.6±17.18  0.0001  192±  42  185±42  >0.05 
LDL (mean±SD)  96±9.15  106.5±18.20  0.0004  119 ±33  117±31  >0.05 
TGL (mean±SD)  148.68±17.7  166.32±12.43  0.0001  112±69  125±83  >0.05 
HDL 
(mean±SD) 
32.32±3.96  32.46±5.24  0.8803  50±16  50±13  >0.05 
 
In this study, TC, LDL, TGL and HDL were all had insignificant difference 
when compared to controls. 
Table:28 COMPARISION OF  RANTAPAA-DAHLAVIST41 et al WITH 
PRESENT STUDY 
LIPID                       PRESENT STUDY              RANTAPAA‐DAHLAVIST et 
al41 
TC(mean)  STUDY  CONTROL        P  
Value 
STUDY  CONTROL      P  value 
TGL(mean)  158.64 
 
172.6  0.0001  219.6  296.4 
0.001 
HDL(mean)  148.68  166.32  0.0001  56.8  69.6  >0.05 
  32.32  32.46  0.8803  56  63.6  <0.05 
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In   RANTAPAA-DAHLAVIST41 et al  ,TC and HDL were significantly 
reduced whereas TGL was insignificantly reduced when compared to controls. 
Table:29 COMPARISION OF PREVIOUS STUDIES WITH PRESENT 
STUDY 
STUDY    TC    LDL    TGL    HDL LP(a) TC/HDL 
Lazarevic 
et al20 
    ↓(S) ↓(S) 
 
↓(S) 
 
↓(S) 
 
  -   - 
Rantapää-
Dahlqvist 
et al41 
    ↓(S)        - ↓(NS) 
 
↓(S) 
 
  -    - 
Svenson et 
al38 
↓(S) ↓(S) ↓(S) ↓(S)   -   - 
Kakati et 
al54 
↓(S) ↓(S) ↓(S) ↓(S)   -   - 
Park 
YB,et al17 
↓(NS) ↓(NS) ↓(NS) ↓(S) ↑(S)   - 
Georgiadis 
et al36. 
↑(S) ↑(S) ↑(S) ↓(S)   - ↑(S) 
Veil 
cobankara 
et al57 
↑(NS) ↑(NS) ↑(S) ↓(S) ↑(S) ↑(S) 
Asanuma 
et al56 
↑(NS) ↑(NS) ↓(NS) No 
difference
↑(S)   - 
Frati et 
al19 
NS NS NS NS   -    - 
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Magaro et 
al53 
NS NS NS ↓(S)   -    - 
Munro et 
al37 
↓(S) ↓(S) ↓(S) ↓(S)   -   - 
Vottery et 
al43 
↓(S) NS ↓(S) NS   -   - 
Lakatos et 
al40 
↑(S) ↑(S) ↓(S) ↓(S)   -   - 
Lorber et 
al18 
 ↓(S)  ↓(S)   -   - 
↓  -Decreased 
↑ -Increased 
S –Significantly 
NS –Not significantly 
  The lipid profile of patients with RA has been evaluated in several of the  
above studies . Most of the  studies, Lazarevic et al, Rantapää-Dahlqvist et al, 
Svenson et al, Kakati et al, Park YB,et al, Munro et al, Nurmohamed Mt et al15, 
had  reported an overall reduction in all lipid sub-fractions in cases of active 
disease. Our  study results are in line with  above mention studies.  
 
   Georgiadis et al36. have reported significantly increased levels of TC, LDL, 
TGL, TC/HDL with reduced  HDL-C. 
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   Veil cobankara et al57 had reported significantly increased TGL, TC/HDL 
with reduced HDL,whereas TC,LDL were insignificantly raised. 
   Asanuma et al56, Frati et al19, had reported insignificant difference between 
RA and controls. Magaro et al53 reported except HDL other lipid subfractions 
are insignificantly changed. 
  Vottery et al43 had reported significant reduced TC, TGL levels. Lakatos et al40 
had reported significantly raised TC, LDL, reduced TGL, HDL. Lorber et al18 
had reported significant reduced  LDL, HDL.  
  Park YB,et al17, Asanuma et al56, Veil cobankara et al57 had  reported 
significantly raised Lipoprotein(a). 
These contrasting results in various previous studies  could be attributed to the 
size of the samples, the type of study (prospective or cross-sectional), 
differences in the disease type (established or early), or to differences in the 
disease activity. 
The favourable  lipid profile in our study cannot explain  increased 
cardiovascular mortality in RA patients. The explanation given by western 
studies for increased cardiovascular mortality in RA patients as follows. 
1. The inflammatory environment and disturbed antioxidant mechanisms in RA 
44  may promote LDL oxidation, thereby facilitating atherogenesis at lower 
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ambient lipid concentrations and placing RA patients at higher cardiovascular 
risk. Though attractive, this hypothesis remains to be tested 
2. presence of circulating autoantibodies to VLDL and LDL in active RA48 . by 
forming immune complexes.  may also have pre-atherogenic effects on the 
vascular wall . 
3.cardiovascular disease in RA may result from accelerated atherosclerosis 
caused by clinical or subclinical vasculitis.45 
4. Reduced cardiovascular fitness caused by immobility37. 
5. medication, increased homocysteine level50, and increased thrombotic factors 
(fibrinogen, von Willebrand factor, plasminogen activator antigen, and fibrin D-
dimer)51 
6. . many similarities have emerged between the inflammation paradigm in the 
pathogenesis of atherosclerosis and the well established inflammation 
mechanism in the pathogenesis of RA49 52. These similarities raise the 
possibility that inflammatory mechanisms responsible for synovial lesions in 
patients with RA may directly participate in producing atherosclerotic lesions 
resulting in excess cardiovascular disease in RA patients60. 
7.Lipoprotein (a), an important independent factor in . atherogenesis and 
thrombogenesis46 is increased in RA correlating positively with the acute phase 
response.46 47. 
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Limitation in our study: 
1. The limitation of this study is that there was no consideration and analysis of 
the effects of patients’ average daily physical activity 
2.The sample size was  likely to be  insufficient , thus we cannot rule out type II 
error in these results. 
    Further research examining the relation between cardiovascular mortality in 
RA  dyslipidaemia, and the effects of chronic inflammation on vascular biology, 
lipids, and atherosclerosis might prove fruitful both to rheumatologists and 
cardiologists. 
 
 
, 
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                                                   CONCLUSION 
 
     The following conclusions were derived from our study. 
1.Patients with Rheumatoid arthritis had significantly reduced levels of serum 
total cholesterol, LDL-cholesterol, triglyceride, as compared to controls. 
2.HDL-cholesterol level was not significantly altered in Rheumatoid arthritis as 
compared to controls. 
3.It is observed that there is significant negative correlation between the  lipid 
parameters -TC, LDL-C, TGL, HDL-C in active Rheumatoid arthritis patients 
and  erythrocyte sedimentation rate .  
4. The lipid parameters TC, TGL were negatively correlated with  duration of 
early morning stiffness ,whereas LDL-C, HDL are insignificantly correlating 
with duration of early morning stiffness in active Rheumatoid arthritis patients. 
5. Though lipid profile is favourable in our study, there is   increased    
cardiovascular mortality in Rheumatoid arthritis patients. 
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Figure:1  LIPID SYNTHESIS, METABOLISM AND 
TRANSPORT. 
                        Figure:2 AGE DISTRIBUTION -STUDY GROUP  
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Figure:4 COMPARISION OF  LIPID VALUES IN STUDY / CONTROL 
GROUPS 
                      
         
 
          
         
         
         
         
         
         
         
         
         
         
      
 
 
 
 
 
 
 
   
                     Figure:5 LIPID DISORDER IN STUDY GROUP 
 
       
 
 
 
 
                
              
 
         
        
        
        
        
        
        
        
        
        
        
        
        
        
        
  
 
 
 
 
 
 
 
 
 
     
  Figure:7 MORNING STIFFNESS DISTRIBUTION IN STUDY GROUP 
          
          
 
           
          
          
          
          
          
          
Figure:6 LIPID DISORDER IN CONTROL GROUP 
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FIGURE:10 CORRELATION  BETWEEN  LIPID                      
ABNORMALITY  AND  ESR 
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                  Figure:11  CORRELATION BETWEEN LIPID ABNORMALITY 
                                    AND EARLY MORNING STIFFNESS 
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Figure:12 CORRELATION BETWEEN ESR AND TC   
CHOLESTEROL    
 
 
 
       
        
        
        
        
        
        
        
        
        
        
        
        
 
  
 
 
     
        
  
 
               Inverse correlation of ESR with TC(r=-0.701 ,p<0.0001 ) 
Figure:13 CORRELATION BETWEEN ESR AND LDL 
CHOLESTEROL   
   
 
 
 
 Figure:14  CORRELATION BETWEEN ESR AND TGL CHOLESTEROL    
        
 
 
 
       
        
        
        
        
        
        
        
        
        
        
        
        
        
        Inverse correlation of ESR with TGL (r= -0.454  ,p= 0.0009 ) 
          Inverse correlation of ESR with LDL-c (r= -0.436 , p=0.0015 ) 
        
 
 
       
        
 Figure:15  CORRELATION BETWEEN ESR AND HDL CHOLESTEROL    
 
 
 
       
        
        
        
        
        
        
        
        
        
         
    
 
    
       
 
        
       
       
       
       
       
       
Figure:16  CORRELATION BETWEEN TC AND 
MORNING STIFFNESS    
        Inverse correlation of ESR with HDL (r= -0.388  ,p= 0.0054 ) 
       
       
       
       
       
       
       
       
        
        
 
 
        
         
 
   
 
    
       
       
       
       
       
       
       
       
       
       
       
       
       
  
 
 
 
 
 
    
        
         
         
         
         
Inverse  correlation of TC with Morning stiffness (r= -0.337, p= 
0.0166)
Figure:17 CORRELATION BETWEEN LDL AND 
MORNING STIFFNESS  
Inverse  correlation of LDL with Morning stiffness (r= -0.103 , p= 
)
Figure:18 CORRELATION BETWEEN TGL AND 
MORNING STIFFNESS 
         
         
         
         
         
         
         
         
       
 
        
       
       
       
       
       
       
       
       
       
       
       
       
       
        
        
 
 
 
 
         
        
Figure:19 CORRELATION BETWEEN HDL AND 
MORNING STIFFNESS 
Inverse  correlation of TGL with Morning stiffness (r= -0.509 , 
p=0.0002) 
        
        
        
        
        
        
        
        
        
        
        
        
 
 
 
Inverse correlation of HDL with Morning stiffness (r= -0.211 , 
0 1419) 
MASTER CHART:STUDY GROUP 
No Name Age 
 
Sex Rcc.No TC 
mgs% 
LDL 
mgs% 
TGL 
mgs%
HDL 
mgs% 
TC/HDL ESR 
mm/hr 
Morning stiffness 
   in minutes 
1 Rani   F 48695 162 104 139 30 5.4 86 50
2 Janaki 53 F 2094 154 98 119 32 4.8 82 60
3 Saroja 55 F 43227 146 90 130 30 4.9 92 90
4 Prema 53 F 45485 176 110 159 34 5.18 48 25
5 Sarada 60 F 49447 163 98 145 36 4.5 90 60
6 Ganesh 27 M 49838 160 103 141 28 5.7 76 70
7 Paulraj 52 M 47554 168 105 147 33 5.1 40 70
8 Amuda 37 F 43998 162 107 125 30 5.4 74 80
9 Saraswathi 45 F 47730 145 78 157 35 4.1 70 90
10 uma 35 F 49229 152 83 163 36 4.2 84 50
11 Vijaya 37 F 40896 172 100 179 36 4.7 38 20
12 Mohana 55 F 50256 172 102 169 36 4.7 56 45
13 Gandhimathi 37 F 43217 152 99 125 28 5.4 92 70
14 Selvanayaki 44 F 50263 170 107 153 32 5.3 58 50
15 Kasthuri 36 F 45010 152 84 169 34 4.5 68 45
16 Sarasu 25 F 47848 158 97 128 35 4.5 90 90
17 Gurunath 67 M 44472 160 94 179 30 5.3 86 45
18 Priya 35 F 49696 144 91 143 24 6 80 70
19 Rajeswari 37 F 49033 166 100 149 36 4.6 44 50
20 Anjali 25 F 46986 142 84 160 26 5.6 98 60
21 Shanthi 50 F 44823 162 105 134 30 5.4 86 90
22 Krishnaveni 28 F 35793 154 97 124 32 4.8 90 40
23 Vimala 30 F 34648 146 90 126 30 4.9 104 40
24 Thilaga 24 F 40648 176 109 164 34 5.17 38 70
      
SNo 
 
Name Age Sex Rcc.No TC 
mgs%
LDL 
mgs%
 
  TGL 
 mgs%
 
HDL 
mgs%
 
TC/HDL ESR 
mm/hr 
Morning stiffness 
in minutes  
 
25 Jayaselan 48 M 49966 163 99 140 36 4.5 80 50
26 Das 49 M 49811 160 102 146 28 5.7 76 45
27 Elcy 44 F 49212 168 106 142 33 5.1 36 80
28 Gunalakshmi 30 F 40682 162 106 130 30 5.4 84 40
29 Munuswamy 23 M 48860 145 79 152 35 4.1 64 45
30 Sivagami 32 F 50016 152 82 168 36 4.2 86 25
31 Rajinisha 35 F 47304 172 101 174 36 4.8 44 30
32 Jamuna 27 F 49698 172 101 174 36 4.8 56 40
33 Indra 50 F 48964 152 100 120 28 5.4 100 70
34 Malliga 45 F 46184 170 106 158 32 5.3 58 60
35 Gowri 30 F 47773 152 85 164 34 4.5 68 50
36 Allice 27 F 50260 158 96 132 35 4.5 96 70
37 Javid 65 M 50067 160 95 174 30 5.3 76 40
38 Vasantha 37 F 39874 144 90 148 24 6 80 60
39 Kanniamal 35 F 23242 166 101 144 36 4.6 44 45
40 Kamala 27 F 23350 142 83 165 26 5.5 98 50
41 Ponnamal 35 F 45611 142 78 138 36 3.9 110 90
42 Mumtaj 40 F 49999 155 91 142 35 4.4 52 35
43 Jayalakshmi 25 F 46140 165 89 176 40 4.1 76 45
44 Kalavathi 20 F 48402 148 90 128 32 4.6 98 60
45 Komathi 70 F 48831 164 105 143 30 5.5 58 40
46 Subbamal 56 F 29419 170 109 143 32 5.3 74 35
47 Geethabai 45 F 45132 152 88 118 28 5.4 108 90
48 Javeena 58 F 49669 162 85 173 42 3.9 72 40
49 Kuppamal 38 F 46147 162 92 174 35 4.6 76 45
50 Chokamal 30 F 45202 160 107 142 24 6.6 86 30
MASRER CHART:CONTROL GROUP 
SNO Name Age Sex OUT 
PATIENT:.N
o 
TC 
mgs% 
LDL 
mgs% 
TGL 
mgs% 
HDL 
mgs% 
TC/HDL ESR 
(mm/hr) 
1 Sangeetha 50 F 51553 154 89 175 30 5.1 6 
2 malathy 54 F 58223 168 97 173 36 4.7 4 
3 Rajeswari 54 F 52980 188 122 169 32 5.9 20 
4 Parimala 53 F 52949 196 130 179 30 6.5 22 
5 kaliammal 60 F 52746 142 83 183 22 6.4 12 
6 kumar 28 M 53640 172 104 169 34 5.1 14 
7 sundar 51 M 58431 182 114 177 32 5.7 16 
8 Rada 39 F 58446 174 106 154 37 4.7 14 
9 
Nagalakshm
i 44 F 58513 176 106 167 36 4.9 12 
10 Venila 34 F 58532 182 122 167 26 7 16 
11 Kanchana 37 F 58536 170 107 171 28 6.1 10 
12 Rajina bee 54 F 58137 192 126 167 32 6 20 
13 Ramani 37 F 58242 152 91 155 30 5.1 8 
14 Uma 45 F 58810 184 129 141 26 7.1 6 
15 Saroja 35 F 57154 182 111 169 37 4.9 4 
16 Saveetha 27 F 57387 184 109 159 43 4.3 18 
17 Narasiman 65 M 58983 174 106 173 33 5.3 16 
18 Valarmathi 35 F 59086 146 74 159 40 3.6 12 
19 Padma 36 F 59387 208 139 175 34 6.1 22 
20 Rosemary 26 F 59537 168 106 157 30 5.6 14 
21 Mangai 51 F 56767 154 89 172 30 5.1 12 
22 Geetha 29 F 58914 168 96 178 36 4.7 10 
23 Shanthi 29 F 59148 188 123 164 32 5.9 16 
24 Saraswathi 23 F 59161 196 129 184 30 6.5 18 
25 Younis 48 M 59581 142 84 178 22 6.4 6 
 
SNO    Name 
 
Age   Sex 
 
OUT 
PATIENT:No 
 
TC 
mgs% 
 
LDL 
mgs% 
 
TGL 
mgs% 
 
HDL 
mgs% 
 
TC/HDL 
 
ESR 
(mm/hr) 
26 Murugan 47 M 59302 172 103 174 34 5.1 10 
27 Mayavathi 46 F 59860 182 115 172 32 5.7 12 
28 Meerajothi 30 F 58081 174 105 160 37 4.7 14 
29 Jayaram 25 M 59549 176 107 162 36 4.9 12 
30 Rosy 30 F 60179 182 121 172 26 7 14 
31 Sankunthala 35 F 60228 170 108 166 28 6.1 10 
32 Arokiamary 28 F 60260 192 125 172 32 6 10 
33 Hemalatha 51 F 59090 152 92 150 30 5.1 8 
34 Alamelu 45 F 60293 184 128 146 26 7.1 16 
35 Kantha 30 F 60722 182 112 164 37 4.9 18 
36 Padma 28 F 60524 184 108 164 43 4.2 8 
37 mani 64 M 55690 174 107 168 33 5.3 6 
38 Suguna 37 F 61803 146 73 164 40 3.6 4 
39 Ragavamal 35 F 62004 208 140 170 34 6.1 18 
40 Salima 28 F 62115 168 105 162 30 5.6 8 
41 Parvathy 34 F 62156 148 71 164 44 3.4 10 
42 Kousalya 40 F 60375 184 120 180 28 6.6 12 
43 Mohana 37 F 60281 152 89 182 26 5.8 8 
44 Antonyamal 35 F 60455 164 87 174 42 3.9 8 
45 Venkatamal 29 F 62180 198 141 132 30 6.6 12 
46 Chinnaponu 33 F 62388 170 109 130 35 4.8 10 
47 Jothy 40 F 62333 174 107 174 32 5.4 14 
48 Valli 27 F 60555 166 109 144 28 5.9 6 
49 Geetha 70 F 62432 154 91 192 24 6.4 8 
50 Shantha 38 F 62543 132 61 162 38 3.5 14 
           
